Zhao H, Sun Y, Feng H, Cai J, Liu Y, Li Y
Int J Biol Sci. 2024; 20(15):6056-6072.
PMID: 39664584
PMC: 11628322.
DOI: 10.7150/ijbs.100525.
Vandewalle N, De Beule N, De Becker A, de Bruyne E, Menu E, Vanderkerken K
Exp Hematol Oncol. 2024; 13(1):99.
PMID: 39367387
PMC: 11453060.
DOI: 10.1186/s40164-024-00566-8.
Kunming C, Jianan Y, Jun L, Shengpeng Z, Qixiang X, Yong X
J Tradit Chin Med. 2024; 44(1):35-43.
PMID: 38213237
PMC: 10774727.
DOI: 10.19852/j.cnki.jtcm.2024.01.004.
Ma Y, Liu F, Zhang Y, Chen Q, Chen Z, Liu Q
Front Immunol. 2022; 13:1024755.
PMID: 36341335
PMC: 9632963.
DOI: 10.3389/fimmu.2022.1024755.
Luo D, He Z, Yu C, Guan Q
Oxid Med Cell Longev. 2022; 2022:6891897.
PMID: 36092154
PMC: 9453003.
DOI: 10.1155/2022/6891897.
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer.
Adam-Artigues A, Arenas E, Martinez-Sabadell A, Braso-Maristany F, Cervera R, Tormo E
Sci Adv. 2022; 8(20):eabk2746.
PMID: 35594351
PMC: 9122332.
DOI: 10.1126/sciadv.abk2746.
AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis.
Goyette M, Cote J
Cancers (Basel). 2022; 14(3).
PMID: 35158733
PMC: 8833413.
DOI: 10.3390/cancers14030466.
Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor-Mediated AXL Phosphorylation.
Bian Q, Anderson J, Zhang X, Huang Z, Ebefors K, Nystrom J
Kidney Med. 2021; 3(6):1003-1013.e1.
PMID: 34939009
PMC: 8664734.
DOI: 10.1016/j.xkme.2021.06.007.
MERTK-Mediated LC3-Associated Phagocytosis (LAP) of Apoptotic Substrates in Blood-Separated Tissues: Retina, Testis, Ovarian Follicles.
Yefimova M, Ravel C, Rolland A, Bourmeyster N, Jegou B
Cells. 2021; 10(6).
PMID: 34207717
PMC: 8229618.
DOI: 10.3390/cells10061443.
HGF/c-Met Axis: The Advanced Development in Digestive System Cancer.
Shao Z, Pan H, Tu S, Zhang J, Yan S, Shao A
Front Cell Dev Biol. 2020; 8:801.
PMID: 33195182
PMC: 7649216.
DOI: 10.3389/fcell.2020.00801.
Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment.
Tanaka M, Siemann D
Cancers (Basel). 2020; 12(7).
PMID: 32660000
PMC: 7408754.
DOI: 10.3390/cancers12071850.
Gas6 expression is reduced in advanced breast cancers.
Ibrahim A, Gray Z, Gomes A, Myers L, Behbod F, Machado H
NPJ Precis Oncol. 2020; 4:9.
PMID: 32352034
PMC: 7181799.
DOI: 10.1038/s41698-020-0116-z.
AXL as a Target in Breast Cancer Therapy.
Colavito S
J Oncol. 2020; 2020:5291952.
PMID: 32148495
PMC: 7042526.
DOI: 10.1155/2020/5291952.
MET targeting: time for a rematch.
Koch J, Aebersold D, Zimmer Y, Medova M
Oncogene. 2020; 39(14):2845-2862.
PMID: 32034310
DOI: 10.1038/s41388-020-1193-8.
Control of cortical synapse development and plasticity by MET receptor tyrosine kinase, a genetic risk factor for autism.
Ma X, Qiu S
J Neurosci Res. 2019; 98(11):2115-2129.
PMID: 31746037
PMC: 7234907.
DOI: 10.1002/jnr.24542.
The Relationships Between Vitamin K and Cognition: A Review of Current Evidence.
Alisi L, Cao R, de Angelis C, Cafolla A, Caramia F, Cartocci G
Front Neurol. 2019; 10:239.
PMID: 30949117
PMC: 6436180.
DOI: 10.3389/fneur.2019.00239.
The RTK Interactome: Overview and Perspective on RTK Heterointeractions.
Paul M, Hristova K
Chem Rev. 2018; 119(9):5881-5921.
PMID: 30589534
PMC: 6918702.
DOI: 10.1021/acs.chemrev.8b00467.
AXL phosphorylates and up-regulates TNS2 and its implications in IRS-1-associated metabolism in cancer cells.
Cheng L, Chen Y, Cheng A, Lee A, Cho C, Huang J
J Biomed Sci. 2018; 25(1):80.
PMID: 30419905
PMC: 6233515.
DOI: 10.1186/s12929-018-0465-x.
HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion.
Li W, Xiong X, Abdalla A, Alejo S, Zhu L, Lu F
J Biol Chem. 2018; 293(40):15397-15418.
PMID: 30108175
PMC: 6177597.
DOI: 10.1074/jbc.RA118.003063.
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges.
Bradley C, Salto-Tellez M, Laurent-Puig P, Bardelli A, Rolfo C, Tabernero J
Nat Rev Clin Oncol. 2017; 14(9):562-576.
PMID: 28374784
DOI: 10.1038/nrclinonc.2017.40.